World's First Nasdaq listed Nature-Derived Psilocybin Biopharma arrives on Wall Street. Thank you Nasdaq for welcoming Psyence Biomedical Ltd (NASDAQ:PBM) #FollowThePsyence
Psyence Biomedical Ltd
Research Services
Psyence Biomed is the World's First NASDAQ-listed Nature-Derived Psilocybin Biopharma
About us
Psyence Biomed Ltd., is a pharmaceutical life science biotechnology company traded on the NASDAQ (NASDAQ:PBM), with a focus on botanical psychedelics. Psyence Biomed is the first Nasdaq-listed nature-derived psilocybin biopharma in the world. The name “Psyence” combines the words “psychedelics” and “science” to affirm our commitment to an evidence-based approach to innovative biopharma. Patient-centered, our physician-led company is led by R+D leader CEO Dr. Neil Maresky, MD, who while working at the intersection of medicine, commerce, and science has brought some 50 medicines to market at AstraZeneca, Wyeth, Bayer, and elsewhere. Psyence Biomed is working to develop an FDA-approved pharmaceutical botanical psilocybin for the treatment of oncology patients diagnosed with Adjustment Disorder in a palliative care context to treat psychosocial distress. Our Phase IIb trials have received ethics approval and begin enrolling patients in this quarter.
- Website
-
https://psyencebiomed.com/
External link for Psyence Biomedical Ltd
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Toronto
- Type
- Public Company
- Founded
- 2023
- Specialties
- Psilocybin and Palliative Care Research
Locations
-
Primary
Get directions
Toronto , CA
Employees at Psyence Biomedical Ltd
Updates
-
Sign-ups now being accepted for Psyence Biomedical Ltd's webinar planned for next Thursday, April 10, when the leadership team takes questions and shares insights and answers about this vertically integrated Nasdaq-listed psychedelic biopharma. https://lnkd.in/eZHtpixB
-
-
Growing our Multi-Asset Biotech Company: Learn how Psyence Biomedical Ltd BioMed is one of the few vertically integrated biopharma companies with a focus on regulated psychedelics and how our expertise in clinical research, scalable production, and global supply, drive value. https://lnkd.in/efc8pmFc
-
Listening and learning as Johns Hopkins Center for Psychedelic and Consciousness Research shares wisdom from the Psyence Biomedical Ltd Scientific Advisory Board Chair Professor Albert Garcia-Romeu, PhD whose work continues to elevate the research field for all.
CPCR Associate Center Director Albert Garcia-Romeu, PhD was interviewed on Texas Public Radio last week. He discusses how psychedelic research can be supported today. https://lnkd.in/e66T2sdZ
-
As we welcome Johns Hopkins Center for Psychedelic and Consciousness Research founding member Professor Albert Garcia-Romeu, PhD as chair of our new Scientific Advisory Board, and Professor Dan Stein, psychiatrist, and world authority on Adjustment Disorder, we also welcome the Psyence Biomedical Ltd presence on X (@PsyenceBiomed) where we share updates, breakthroughs, and deepen the conversation about Palliative Care and FDA-regulated psychedelic medicine for oncology patients.
-
Join Psyence Biomedical Ltd for key updates on clinical research, our new Scientific Advisory Board, and the future of psychedelic therapeutics. Date: Thursday, April 10, 2025 Time: 12:00 PM EDT Register here: https://lnkd.in/eZHtpixB for an Ask Us Anything conversation and live Q&A session with the Psyence Biomedical Ltd executive team: Dr. Neil Maresky, CEO, Dr. Clive Ward-Able Medical Director, and Warwick Corden-Lloyd, CFO.
-
-
Psyence Biomedical Ltd emerges from stealth to announce ALL STAR team of scientific advisors as Professor Dan Stein MD joins Yale School of Medicine's Dr. Seth Feuerstein MD, and Johns Hopkins Center for Psychedelic and Consciousness Research Associate Director Professor Albert Garcia-Romeu, PhD https://lnkd.in/eS5uW_Bg
-
Psychedelic Invest - Insights and Analyses on Psychedelics has shared the news that Professor Albert Garcia-Romeu, PhD of Johns Hopkins Center for Psychedelic and Consciousness Research has joined Psyence Biomedical Ltd as chair of its Scientific Advisory Board. https://lnkd.in/e7sYpFZv
-
Thank you BioSpace for the warm welcome to Professor Albert Garcia-Romeu, PhD of Johns Hopkins Center for Psychedelic and Consciousness Research as he joins Psyence Biomedical Ltd as chair of its Scientific Advisory Board! https://lnkd.in/ecKTpjha